Source: Bone marrow transplantation [Bone Marrow Transplant] 2015 Nov; Vol. 50 (11), pp. 1393-404. Date of Electronic Publication: 2015 Aug 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.

Authors : Sung KW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Republic of Korea. ; Son MH

Subjects: Induction Chemotherapy*/Induction Chemotherapy*/Induction Chemotherapy*/adverse effects ; Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/adverse effects; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

Source: Bone marrow transplantation [Bone Marrow Transplant] 2013 Jan; Vol. 48 (1), pp. 68-73. Date of Electronic Publication: 2012 May 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.

Authors : Drabko K; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland. ; Raciborska A

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*drug therapy ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*surgery

Source: Bone marrow transplantation [Bone Marrow Transplant] 2012 Dec; Vol. 47 (12), pp. 1530-4. Date of Electronic Publication: 2012 May 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.

Authors : Stemmer SM; Department of Oncology and Radiotherapy, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Hardan I

Subjects: Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/adverse effects; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*therapy

Source: Bone marrow transplantation [Bone Marrow Transplant] 2003 Apr; Vol. 31 (8), pp. 655-61.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.

Authors : Gutierrez-Delgado F; Fred Hutchinson Cancer Research, University of Washington and Puget Sound Oncology Consortium, Seattle, WA 98109-1024, USA.; Holmberg LA

Subjects: Hematopoietic Stem Cell Transplantation*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*therapy

Source: Bone marrow transplantation [Bone Marrow Transplant] 2000 Jul; Vol. 26 (1), pp. 51-9.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Editorial & Opinion

High-dose therapy in breast cancer: out of favor but not out of promise.

Authors : Glück S; Stewart D

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/administration & dosage

Source: Bone marrow transplantation [Bone Marrow Transplant] 2000 May; Vol. 25 (10), pp. 1017-9.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.

Authors : Vij R; Washington University School of Medicine, Division of Bone Marrow Transplantation and Stem Cell Biology, St Louis, MO 63110-1093, USA.; DiPersio J

Source: Bone marrow transplantation [Bone Marrow Transplant] 2000 Nov; Vol. 26 (9), pp. 947-53.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Authors : Martínez-Climent JA; Department of Hematology and Medical Oncology, Hospital Clinico Universitario, University of Valencia, Spain.; Comes AM

Subjects: Chromosome Aberrations*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics CAF protocol; FEC protocol

Source: Bone marrow transplantation [Bone Marrow Transplant] 2000 Jun; Vol. 25 (11), pp. 1203-8.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast.

Authors : Schwartzberg L; Clinical Research Division of Response Oncology, Inc., Memphis, TN, USA.; Weaver C

Subjects: Hematopoietic Stem Cell Transplantation*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*therapy

Source: Bone marrow transplantation [Bone Marrow Transplant] 1999 Nov; Vol. 24 (9), pp. 981-7.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Results of a pilot study of 40 patients using high-dose therapy with hematopoietic rescue after standard-dose adjuvant therapy for high-risk breast cancer.

Authors : Tomás JF; Department of Hematology, Universidad Autónoma de Madrid. Hospital Universitario de la Princesa, Spain.; Pérez-Carrión R

Source: Bone marrow transplantation [Bone Marrow Transplant] 1997 Feb; Vol. 19 (4), pp. 331-6.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي